Christopher J. Corrigan
About
In The Last Decade
Christopher J. Corrigan
232 papers receiving 17.5k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Physiology 12.6k
- Immunology 7.6k
- Pulmonary and Respiratory Medicine 5.3k
- Immunology and Allergy 4.8k
- Surgery 2.2k
Countries citing papers authored by Christopher J. Corrigan
This map shows the geographic impact of Christopher J. Corrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Corrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Corrigan more than expected).
Fields of papers citing papers by Christopher J. Corrigan
This network shows the impact of papers produced by Christopher J. Corrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Corrigan. The network helps show where Christopher J. Corrigan may publish in the future.
Co-authorship network of co-authors of Christopher J. Corrigan
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Corrigan. A scholar is included among the top collaborators of Christopher J. Corrigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Corrigan. Christopher J. Corrigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 4 | |
| 4 | 7 | |
| 5 | 31 | |
| 6 | 47 | |
| 7 | 67 | |
| 8 | A Randomised, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy Of Oral Azithromycin (500 Mg Od) As A Supplement To Standard Care For Adult Patients With Acute Exacerbations Of Asthma (the Azalea Trial) | 1 |
| 9 | Vitamin D increases the frequency of FoxP3+ Tregs in vitro and in vivo: differential role for IL-2 and IL-10 | 1 |
| 10 | 119 | |
| 11 | IL-25 promotes bFGF expression by human endothelial cells through interaction with IL-17RB, but not IL-17RA: a novel mechanism for tissue remodelling | 0 |
| 12 | 89 | |
| 13 | 14 | |
| 14 | 276 | |
| 15 | Difficult therapy-resistant asthma: Role of inflammatory cells | 1 |
| 16 | The Battle for Australia's Waterfront | 10 |
| 17 | Increased expression of high affinity IGE receptor (FCεRI) α chain mRNA and protein bearing eosinophils in human allergen-induced atopic asthma | 1 |
| 18 | Enhanced expression of high affinity IgE receptor (Fc epsilon RI) or chain bearing eosinophils in human allergen-induced asthma. | 1 |
| 19 | 5 | |
| 20 | Antibodies to viral and other antigens in blood serum of children resident in the northwest territories. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.